Tomeki

Explore Books on
dopa

1-24 of 25 Books

View Awakenings By Oliver Sacks,Jonathan Davis
Cover of Awakenings by oliver sacks,jonathan davis

Awakenings

By Oliver Sacks,Jonathan Davis

View L-Dopa and Parkinsonism By Manuel Riklan
Cover of L-Dopa and Parkinsonism by manuel riklan

L-Dopa and Parkinsonism

By Manuel Riklan

View Neurobiology of DOPA as a neurotransmitter By Yoshimi Misu
Cover of Neurobiology of DOPA as a neurotransmitter by yoshimi misu

Neurobiology of DOPA as a neurotransmitter

By Yoshimi Misu

View Developments in treatment for Parkinson's disease By George C. Cotzias

Developments in treatment for Parkinson's disease

Developments in treatment for Parkinson's disease

By George C. Cotzias

View The Clinical Uses of L-Dopa By G. Stern

The Clinical Uses of L-Dopa

The Clinical Uses of L-Dopa

By G. Stern

View The Treatment of Parkinsonism with L-Dopa By Marks, John
Cover of The Treatment of Parkinsonism with L-Dopa by marks, john

The Treatment of Parkinsonism with L-Dopa

By Marks, John

View Catechol- and indolamines in some endocrine cell systems By Hans Tjälve

Catechol- and indolamines in some endocrine cell systems

Catechol- and indolamines in some endocrine cell systems

By Hans Tjälve

View Catecholamine turnover in central nervous system By Torgny Persson

Catecholamine turnover in central nervous system

Catecholamine turnover in central nervous system

By Torgny Persson

View Catechol derivatives in the skin of young mice By Lennart Cegrell

Catechol derivatives in the skin of young mice

Catechol derivatives in the skin of young mice

By Lennart Cegrell

View The interactions of cholinergic and anticholinergic drugs with nigro-neostriatal dopaminergic neurons By Robyn G. Young
Cover of The interactions of cholinergic and anticholinergic drugs with nigro-neostriatal dopaminergic neurons by robyn g. young

The interactions of cholinergic and anticholinergic drugs with nigro-neostriatal dopaminergic neurons

By Robyn G. Young

View Parlodel® (bromocriptine mesylate) in the early management of Parkinson's disease By Stanley Fahn

Parlodel® (bromocriptine mesylate) in the early management of Parkinson's disease

Parlodel® (bromocriptine mesylate) in the early management of Parkinson's disease

By Stanley Fahn

View Biosynthetic studies on the chromophore of pseudobactin from Pseudomonas fluorescens B10 By Brian Nowak-Thompson

Biosynthetic studies on the chromophore of pseudobactin from Pseudomonas fluorescens B10

Biosynthetic studies on the chromophore of pseudobactin from Pseudomonas fluorescens B10

By Brian Nowak-Thompson

View Effects of feeding chicks high and low levels of tyrosine and dopa on toxicity and growth performance By Judith Jourdain-Poitevien

Effects of feeding chicks high and low levels of tyrosine and dopa on toxicity and growth performance

Effects of feeding chicks high and low levels of tyrosine and dopa on toxicity and growth performance

By Judith Jourdain-Poitevien

View L-DOPA and behavior By Sidney Malitz

L-DOPA and behavior

L-DOPA and behavior

By Sidney Malitz

View Cardiovascular and renal effects of L-Dopa By T. Budya Tjandramaga

Cardiovascular and renal effects of L-Dopa

Cardiovascular and renal effects of L-Dopa

By T. Budya Tjandramaga

View Age-related dopamine-dependent disorders By International Symposium on Age-Related Monoamine-Dependent Disorders and Their Modulation by Gene and Gender (1993 Tokyo, Japan)
Cover of Age-related dopamine-dependent disorders by international symposium on age-related monoamine-dependent disorders and their modulation by gene and gender (1993 tokyo, japan)

Age-related dopamine-dependent disorders

By International Symposium on Age-Related Monoamine-Dependent Disorders and Their Modulation by Gene and Gender (1993 Tokyo, Japan)

View Parkinson's disease By Mark F. Lew,Cheryl H. Waters
Cover of Parkinson's disease by mark f. lew,cheryl h. waters

Parkinson's disease

By Mark F. Lew,Cheryl H. Waters

View Synthesis of 6-alkyl derivatives of DOPA via the trans isomers of unsaturated azlactones By Abraham Pieter Morgenstern

Synthesis of 6-alkyl derivatives of DOPA via the trans isomers of unsaturated azlactones

Synthesis of 6-alkyl derivatives of DOPA via the trans isomers of unsaturated azlactones

By Abraham Pieter Morgenstern

View L-Dopa and Parkinsonism By Fletcher H. McDowell
Cover of L-Dopa and Parkinsonism by fletcher h. mcdowell

L-Dopa and Parkinsonism

By Fletcher H. McDowell

View Neurobiology of DOPA as a neurotransmitter By
Cover of Neurobiology of DOPA as a neurotransmitter by

Neurobiology of DOPA as a neurotransmitter

By

View The Clinical uses of Levodopa By Stern, Gerald
Cover of The Clinical uses of Levodopa by stern, gerald

The Clinical uses of Levodopa

By Stern, Gerald

View Pathogenic problems of phenolase enzymatic oxidation of catecholamines and dopa in humans By E. Koch

Pathogenic problems of phenolase enzymatic oxidation of catecholamines and dopa in humans

Pathogenic problems of phenolase enzymatic oxidation of catecholamines and dopa in humans

By E. Koch

View Current concepts in the treatment of Parkinsonism By

Current concepts in the treatment of Parkinsonism

Current concepts in the treatment of Parkinsonism

By

View L-DOPA and behavior By Sidney Malitz
Cover of L-DOPA and behavior by sidney malitz

L-DOPA and behavior

By Sidney Malitz